Pharma BD Deal Intelligence
Biogen Inc. / Nightstar Therapeutics
2019 · Acquisition/Merger · $800M · Complete
Announcement Sentiment
75
Strongly positive
Outcome Score
28
Did not work — the deal failed to deliver.
Biogen acquired Nightstar for $800M for gene therapy for inherited retinal disorders.
Key facts
- Announced Mar 04, 2019
- Closed Jun 07, 2019
- Deal value $800M
- Deal type Acquisition/Merger
- Therapeutic area Ophthalmology
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals